Arrowstreet Capital, Limited Partnership Takeda Pharmaceutical CO LTD Transaction History

Arrowstreet Capital, Limited Partnership

$136 Billion
Q2 2025

A detailed history of Arrowstreet Capital, Limited Partnership transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Arrowstreet Capital, Limited Partnership holds 1,218,690 shares of TAK stock, worth $17.8 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,218,690

Previous 1,400,456 12.98%

Holding current value

$17.8 Million

Previous $20.8 Million 9.53%

% of portfolio

0.01%

Previous 0.02%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	SELL	$13.71 - $15.46 $2.49 Million - $2.81 Million	-181,766 Reduced 12.98%	1,218,690 $18.8 Million
Q1 2025 May 14, 2025	SELL	$12.89 - $15.19 $36.3 Million - $42.8 Million	-2,815,917 Reduced 66.79%	1,400,456 $20.8 Million
Q4 2024 Feb 12, 2025	SELL	$13.01 - $14.43 $5.45 Million - $6.05 Million	-419,019 Reduced 9.04%	4,216,373 $55.8 Million
Q3 2024 Nov 14, 2024	BUY	$13.0 - $15.08 $30.2 Million - $35 Million	2,319,877 Added 100.19%	4,635,392 $65.9 Million
Q2 2024 Aug 14, 2024	BUY	$12.6 - $13.67 $12 Million - $13 Million	950,588 Added 69.64%	2,315,515 $30 Million
Q1 2024 May 15, 2024	SELL	$13.89 - $15.04 $7.55 Million - $8.17 Million	-543,294 Reduced 28.47%	1,364,927 $19 Million
Q4 2023 Feb 14, 2024	SELL	$13.36 - $15.43 $7.56 Million - $8.73 Million	-565,689 Reduced 22.87%	1,908,221 $27.2 Million
Q3 2023 Nov 14, 2023	BUY	$15.03 - $16.32 $2.1 Million - $2.28 Million	139,715 Added 5.99%	2,473,910 $38.3 Million
Q2 2023 Aug 14, 2023	BUY	$15.57 - $17.11 $19.9 Million - $21.8 Million	1,276,920 Added 120.77%	2,334,195 $36.7 Million
Q1 2023 May 15, 2023	SELL	$15.28 - $16.48 $43.5 Million - $46.9 Million	-2,847,021 Reduced 72.92%	1,057,275 $17.4 Million
Q4 2022 Feb 14, 2023	BUY	$12.42 - $15.62 $30.6 Million - $38.5 Million	2,465,178 Added 171.3%	3,904,296 $60.9 Million
Q3 2022 Nov 14, 2022	BUY	$12.8 - $28.65 $5.2 Million - $11.6 Million	406,032 Added 39.3%	1,439,118 $18.7 Million
Q2 2022 Aug 15, 2022	BUY	$13.12 - $15.03 $11.4 Million - $13.1 Million	871,373 Added 538.84%	1,033,086 $14.5 Million
Q1 2022 May 13, 2022	BUY	$13.54 - $15.35 $2.19 Million - $2.48 Million	161,713 New	161,713 $2.32 Million
Q3 2021 Nov 12, 2021	SELL	$16.3 - $17.26 $1.43 Million - $1.51 Million	-87,700 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$16.55 - $18.64 $2.87 Million - $3.23 Million	-173,431 Reduced 66.42%	87,700 $1.48 Million
Q1 2021 May 14, 2021	BUY	$16.71 - $19.9 $500,514 - $596,064	29,953 Added 12.96%	261,131 $4.77 Million
Q4 2020 Feb 12, 2021	SELL	$15.39 - $18.97 $3.36 Million - $4.15 Million	-218,567 Reduced 48.6%	231,178 $4.21 Million
Q3 2020 Nov 12, 2020	SELL	$17.1 - $19.19 $1.45 Million - $1.63 Million	-84,833 Reduced 15.87%	449,745 $8.02 Million
Q2 2020 Aug 12, 2020	BUY	$14.59 - $19.5 $1.74 Million - $2.33 Million	119,577 Added 28.81%	534,578 $9.59 Million
Q1 2020 May 15, 2020	BUY	$13.02 - $20.31 $4.83 Million - $7.54 Million	371,118 Added 845.7%	415,001 $6.3 Million
Q4 2019 Feb 13, 2020	BUY	$16.88 - $20.83 $740,745 - $914,082	43,883 New	43,883 $866,000
Q2 2019 Aug 14, 2019	SELL	$16.58 - $20.49 $70 Million - $86.5 Million	-4,220,584 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$16.7 - $21.52 $7.49 Million - $9.65 Million	448,339 Added 11.89%	4,220,584 $86 Million
Q4 2018 Feb 14, 2019	BUY	$15.64 - $21.1 $59 Million - $79.6 Million	3,772,245 New	3,772,245 $63.4 Million

Others Institutions Holding TAK

# of Institutions

368

Shares Held

73.1M

Call Options Held

1.68M

Put Options Held

157K

View Full List

About TAKEDA PHARMACEUTICAL CO LTD

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $45.5B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

More about TAK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.

Account

Arrowstreet Capital, Limited Partnership Takeda Pharmaceutical CO LTD Transaction History